Estrella Immunopharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -3,376 | -3,949 | -469 | -1,020 |
EBIT | -429 | -1,142 | ||
Net Income | -3,376 | -3,951 | -469 | -1,020 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,217 | -291 | -4,234 | -11,266 |
Cash | 1,797 | 4,165 | 4,727 | 9,046 |
Basic Shares | 36,208 | 35,519 | 35,519 | 35,201 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -915 | -1,685 | |
EBIT | -1,143 | -1,685 | |
Net Income | -7,311 | -996 | -1,685 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -16,068 | -1,043 | -1,442 |
Cash | 4,165 | 40 | 4,088 |
Basic Shares | 36,289 | 5,762 | 5,849 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.09 |
2024-06-30 | -$0.10 |
2024-03-31 | -$0.01 |
2023-12-31 | -$0.02 |
